相似文献
1
Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120.
ChemMedChem. 2011 Aug 1;6(8):1335-9, 1318. doi: 10.1002/cmdc.201100177. Epub 2011 Jun 28.
2
Non-natural peptide triazole antagonists of HIV-1 envelope gp120.
ChemMedChem. 2013 Feb;8(2):322-8. doi: 10.1002/cmdc.201200422. Epub 2012 Dec 13.
3
Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
Future Med Chem. 2015;7(17):2305-10. doi: 10.4155/fmc.15.152. Epub 2015 Nov 24.
4
The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
ChemMedChem. 2010 Nov 8;5(11):1871-9. doi: 10.1002/cmdc.201000222.
5
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
Retrovirology. 2021 Oct 9;18(1):31. doi: 10.1186/s12977-021-00575-z.
6
Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
J Biol Chem. 2015 Jan 2;290(1):529-43. doi: 10.1074/jbc.M114.608315. Epub 2014 Nov 4.
7
A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.
Biochemistry. 2013 Apr 2;52(13):2245-61. doi: 10.1021/bi400166b. Epub 2013 Mar 22.
8
Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
J Mol Recognit. 2009 Mar-Apr;22(2):169-74. doi: 10.1002/jmr.892.
9
Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors.
Antimicrob Agents Chemother. 2012 Feb;56(2):1073-80. doi: 10.1128/AAC.05555-11. Epub 2011 Nov 14.
10
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
J Med Chem. 2008 May 8;51(9):2638-47. doi: 10.1021/jm070814r. Epub 2008 Apr 11.
引用本文的文献
1
Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection.
J Virol. 2025 Mar 18;99(3):e0147124. doi: 10.1128/jvi.01471-24. Epub 2025 Feb 6.
2
Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability.
Curr Protein Pept Sci. 2023;24(1):59-77. doi: 10.2174/1389203723666220610120927.
3
Peptide-Based HIV Entry Inhibitors.
Adv Exp Med Biol. 2022;1366:15-26. doi: 10.1007/978-981-16-8702-0_2.
4
Computational Modeling of the Virucidal Inhibition Mechanism for Broad-Spectrum Antiviral Nanoparticles and HPV16 Capsid Segments.
J Phys Chem B. 2021 Dec 9;125(48):13122-13131. doi: 10.1021/acs.jpcb.1c07436. Epub 2021 Nov 30.
5
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
Retrovirology. 2021 Oct 9;18(1):31. doi: 10.1186/s12977-021-00575-z.
6
Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.
Microorganisms. 2021 Jun 12;9(6):1286. doi: 10.3390/microorganisms9061286.
7
Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells.
Front Microbiol. 2020 May 25;11:1063. doi: 10.3389/fmicb.2020.01063. eCollection 2020.
8
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.
J Pept Sci. 2019 Apr;25(4):e3155. doi: 10.1002/psc.3155. Epub 2019 Feb 27.
9
Mechanical characterization of HIV-1 with a solid-state nanopore sensor.
Electrophoresis. 2019 Mar;40(5):776-783. doi: 10.1002/elps.201800311. Epub 2018 Sep 7.
10
Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface.
J Med Chem. 2018 Jun 14;61(11):5020-5033. doi: 10.1021/acs.jmedchem.8b00477. Epub 2018 Jun 1.
本文引用的文献
1
The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
ChemMedChem. 2010 Nov 8;5(11):1871-9. doi: 10.1002/cmdc.201000222.
2
Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
J Biol Chem. 2010 Aug 13;285(33):25743-52. doi: 10.1074/jbc.M110.144121. Epub 2010 Jun 10.
3
Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
PLoS Pathog. 2009 Apr;5(4):e1000360. doi: 10.1371/journal.ppat.1000360. Epub 2009 Apr 3.
4
Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
J Mol Recognit. 2009 Mar-Apr;22(2):169-74. doi: 10.1002/jmr.892.
5
Inhibition of HIV fusion with multivalent gold nanoparticles.
J Am Chem Soc. 2008 Jun 4;130(22):6896-7. doi: 10.1021/ja710321g. Epub 2008 May 13.
6
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
J Med Chem. 2008 May 8;51(9):2638-47. doi: 10.1021/jm070814r. Epub 2008 Apr 11.
7
Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120.
J Biol Chem. 2007 Sep 21;282(38):27754-9. doi: 10.1074/jbc.M702025200. Epub 2007 Jun 28.
8
Broad-spectrum anti-human immunodeficiency virus (HIV) potential of a peptide HIV type 1 entry inhibitor.
J Virol. 2007 Apr;81(7):3645-8. doi: 10.1128/JVI.01778-06. Epub 2007 Jan 24.
9
Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.
ChemMedChem. 2006 Jan;1(1):54-7. doi: 10.1002/cmdc.200500037.
10
Virus membrane-fusion proteins: more than one way to make a hairpin.
Nat Rev Microbiol. 2006 Jan;4(1):67-76. doi: 10.1038/nrmicro1326.
Zotero 插件